Novel Carrier Peptide
- 总结
- A cell penetrating peptide designated Xentry derived from the X-protein of the hepatitis B virus
- 技术优势
- It is small compared to other known peptides, therefore costs of goods are lower. Uptake is more controllable.
- 技术应用
- Therapeutic or life sciences tool platform
- 申请日期
- 40704
- 申请号码
- PCT/NZ2011/000102
- 其他
- We have identified a novel cell penetrating peptide designated Xentry derived from the X-protein of the hepatitis B virus. It is the smallest known carrier peptide -only 5 amino acids in length. It holds a therapeutic advantage in that it is not taken up by non-adherent cells, hence will not be sequestered and diluted by blood cells following injection, thereby enabling more efficient targeting of tissues.
- ID号码
- 1656099
- 国家/地区
- 新西兰
欲了解更多信息，请点击 这里
